Suchergebnisse - "Tursi, Antonio"

PubPharm (21)

1

Clinical use of biologics for Crohn's disease in adults : lessons learned from real-world studies

enthalten in: Expert opinion on biological therapy | 2024

von Tursi, A. | Mocci, G. | Del Gaudio, A. | +1

2

Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases : A Real-Life, Multicenter, Observational Study

enthalten in: Inflammatory bowel diseases | 2023

von Tursi, A. | Mocci, G. | Allegretta, L. | +47

ErratumIn: Inflamm Bowel Dis. 2022 Oct 3;28(10):e145. - PMID 35820045

3

Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease : A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2022

von Tursi, A. | Mocci, G. | Cuomo, A. | +89

4

Therapeutic Response to Adalimumab in a Case of Steroid-Dependent Segmental Colitis Associated With Diverticulosis

enthalten in: The American journal of gastroenterology | 2021

von Tursi, A. | Nenna, R. | Danese, S.

5

SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2021

von Tursi, A. | Tiano, M.

6

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

enthalten in: European journal of gastroenterology & hepatology | 2021

von Tursi, A. | Mocci, G. | Lorenzetti, R. | +26

CommentIn: Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1088. - PMID 35048671

7

Histological Remission in Ulcerative Colitis in Deep Remission under Treatment with Adalimumab

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2021

von Tursi, A. | Nenna, R. | Musci, G. | +2

8

Impact of Anti-TNFα Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases

enthalten in: Journal of Crohn's & colitis | 2020

von Tursi, A. | Papa, A.

9

COVID-19 infection in Crohn's disease under treatment with adalimumab

enthalten in: Gut | 2020

von Tursi, A. | Angarano, G. | Monno, L. | +4

CommentOn: Gut. 2020 Jun;69(6):1002-1009. - PMID 32213556

10

Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis : A real-life multicenter, observational study in primary inflammatory bowel disease centers

enthalten in: Medicine | 2018

von Tursi, A. | Elisei, W. | Faggiani, R. | +20